<DOC>
	<DOCNO>NCT02746068</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled , 24-week study evaluate efficacy safety AXS-02 subject knee osteoarthritis associate bone marrow lesion .</brief_summary>
	<brief_title>A Study Assess Efficacy Safety AXS-02 Subjects With Knee OA Associated With Bone Marrow Lesions</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Key Male least 50 year age , postmenopausal female Meets ACR clinical criterion knee osteoarthritis Bone Marrow Lesion knee present MRI Additional criterion may apply Key Previous surgery index knee Any prior use bisphosphonates within 6 month screen Additional criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Bone Marrow Lesions</keyword>
	<keyword>AXS02</keyword>
	<keyword>Axsome</keyword>
	<keyword>Knee OA</keyword>
	<keyword>Osteoarthritis</keyword>
</DOC>